Abstract
Background
Extracellular adenosine has been shown to induce apoptosis in a variety of cells via an intrinsic pathway linked to adenosine uptake into cells and the ensuing signaling cascades and an extrinsic pathway linked to adenosine receptors. The present study was designed to understand the mechanism underlying adenosine-induced apoptosis of Caco-2 human colonic cancer cells.
Methods
To observe cell viability, an MTT assay was carried out in Caco-2 cells untransfected or transfected with the A2a adenosine receptor pcDNA3.1. Apoptotic cell death was assessed with flow cytometry using propidium iodide and annexin V and internucleosomal DNA fragmentation analysis. Activities of caspase-3, -8, and -9 were measured using a caspase fluorometric assay kit. Mitochondrial membrane potentials were monitored using a DePsipher kit. Expression of adenosine receptors was examined with the reverse transcription-polymerase chain reaction (RT-PCR) method.
Results
Extracellular adenosine induced Caco-2 cell apoptosis in a concentration-dependent (1–20 mM) and treatment time-dependent (24–72 h) manner. The adenosine effect was inhibited by DMPX, an inhibitor of A2a adenosine receptors and SQ22536, an inhibitor of adenylate cyclase. CGS21680, an agonist of A2a adenosine receptors, and forskolin, an adenylate cyclase activator, mimicked the adenosine action. Caco-2 cell death was still induced by overexpressing A2a adenosine receptors, and adenosine further promoted the cell death. Adenosine disrupted mitochondrial membrane potentials and activated caspase-9 and -3, but not caspase-8.
Conclusions
Extracellular adenosine induces apoptosis in Caco-2 cells by activating caspase-9 and the downstream effector caspase caspase-3 in association with mitochondrial damage via A2a adenosine receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383–424.
Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614–620.
Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309–1312.
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479–489.
Zou H, Li Y, Liu X, Wang X. An APAF-1.-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549–11556.
Mori M, Nishizaki T, Okada Y. Protective effect of adenosine on the anoxic damage of hippocampal slice. Neuroscience 1992;46:301–307.
Schrier SM, van Tilburg EW, van der Meulen H, Ijzerman AP, Mulder GJ, Nagelkerke JF. Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. Biochem Pharmacol 2001;61:417–425.
Barry CP, Lind SE. Adenosine-mediated killing of cultured epithelial cancer cells. Cancer Res 2000;60:1887–1894.
Saitoh M, Nagai K, Nakagawa K, Yamamura T, Yamamoto S, Nishizaki T. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem Pharmacol 2004;67:2005–2011.
Yang D, Yaguchi T, Yamamoto H, Nishizaki T. Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3/-8 activation. Biochem Pharmacol 2007;73:1665–1675.
Peyot ML, Gadeau AP, Dandre F, Belloc I, Dupuch F, Desgranges C. Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A2b-purinoceptor. Circ Res 2000;86:76–85.
Vintermyr OK, Gjertsen BT, Lanotte M, Doskeland SO. Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells. Exp Cell Res 1993;206:157–161.
Boe R, Gjertsen BT, Doskeland SO, Vintermyr OK. 8-ChlorocAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line. Br J Cancer 1995;72:1151–1159.
Pratt RM, Martin GR. Epithelial cell death and cyclic AMP increase during palatal development. Proc Natl Acad Sci U S A 1975;72:874–877.
Zwain IH, Amato P. cAMP-induced apoptosis in granulosa cells is associated with up-regulation of P53 and bax and downregulation of clusterin. Endocr Res 2001;27:233–249.
Mentz F, Mossalayi MD, Ouaaz F, Debre P. Involvement of cAMP in CD3 T cell receptor complex- and CD2-mediated apoptosis of human thymocytes. Eur J Immunol 1995;25:1798–1801.
Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB. TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 1995;154:1634–1643.
Aoshiba K, Nagai A, Konno K. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother 1995;39:872–877.
Grbovic O, Jovic V, Ruzdijic S, Pejanovic V, Rakic L, Kanazir S. 8-Cl-cAMP affects glioma cell-cycle kinetics and selectively induces apoptosis. Cancer Invest 2002;20:972–982.
Cummings BS, Schnellmann RG. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 2002;302:8–17.
Vanags DM, Porn-Ares MI, Coppola S, Burgess DH, Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 1996;271:31075–31085.
Pietra G, Mortarini R, Parmiani G, Anichini A. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells. Cancer Res 2001;61:8218–8226.
Meester BJ, Shankley NP, Welsh NJ, Meijler FL, Black JW. Pharmacological analysis of the activity of the adenosine uptake inhibitor, dipyridamole, on the sinoatrial and atrioventricular nodes of the guinea-pig. Br J Pharmacol 1998;124:729–741.
Wiesner JB, Ugarkar BG, Castellino AJ, Barankiewicz J, Dumas DP, Gruber HE, et al. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J Pharmacol Exp Ther 1999;289:1669–1677.
Chen YI, Choi JK, Jenkins BG. Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI. Synapse 2005;55:80–88.
Bauman LA, Mahle CD, Boissard CG, Gribkoff VK. Age-dependence of effects of A1 adenosine receptor antagonism in rat hippocampal slices. J Neurophysiol 1992;68:629–638.
Trincavelli ML, Marroni M, Tuscano D, Ceruti S, Mazzola A, Mitro N, et al. Regulation of A2B adenosine receptor functioning by tumour necrosis factor-α in human astroglial cells. J Neurochem 2004;91:1180–1190.
Li AH, Moro S, Forsyth N, Melman N, Ji XD, Jacobson KA. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem 1999;42:706–721.
Cunha RA, Constantino MD, Ribeiro JA. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br J Pharmacol 1997;122:1279–1284.
Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 2000;362:364–374.
Turcato S, Clapp LH. Effects of the adenylyl cyclase inhibitor SQ22536 on iloprost-induced vasorelaxation and cyclic AMP elevation in isolated guinea-pig aorta. Br J Pharmacol 1999;126:845–847.
Wei T, Chen C, Hou J, Zhao B, Xin W, Mori A. The antioxidant EPC-K1 attenuates NO-induced mitochondrial dysfunction, lipid peroxidation and apoptosis in cerebellar granule cells. Toxicology 1999;134:117–126.
Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996;86:147–157.
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (Lond) 1999;397:441–446.
Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000;102:33–42.
Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000;102:43–53.
Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001;8:613–621.
Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 2002;277:432–438.
Grbovic O, Jovic V, Ruzdijic S, Pejanovic V, Rakic L, Kanazir S. 8-Cl-cAMP affects glioma cell-cycle kinetics and selectively induces apoptosis. Cancer Invest 2002;20:972–982.
Martin MC, Dransfield I, Haslett C, Rossi AG. Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J Biol Chem 2001;276:45041–45050.
Ding HF, McGill G, Rowan S, Schmaltz C, Shimamura A, Fisher DE. Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J Biol Chem 1998;273:28378–28383.
Parvathenani LK, Buescher ES, Chacon-Cruz E, Beebe SJ. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3. J Biol Chem 1998;273:6736–6743.
Yusta B, Boushey RP, Drucker DJ. The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway. J Biol Chem 2000;275:35345–35352.
Suzuki A, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K. Procaspase 3/p21 complex formation to resist fasmediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A. Cell Death Differ 2000;7:721–728.
Li J, Yang S, Billiar TR. Cyclic nucleotides suppress tumor necrosis factor α-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation. J Biol Chem 2000;275:13026–13034.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yasuda, Y., Saito, M., Yamamura, T. et al. Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A2a adenosine receptors. J Gastroenterol 44, 56–65 (2009). https://doi.org/10.1007/s00535-008-2273-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-008-2273-7